RecruitingNCT03826264
Transpacific TAVR Registry
a Multinational Multicenter Prospective Transpacific TAVR Registry
Sponsor
Duk-Woo Park, MD
Enrollment
10,000 participants
Start Date
Jun 15, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Eligibility
Min Age: 19 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a procedure called TAVR for people with aortic valve insufficiency and heart valve diseases. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 19 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURETAVR
transcatheter aortic valve replacement (TAVR)
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03826264
Related Trials
The TRICURE EFS Study
NCT0650694210 locations
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NCT0660882329 locations
The Study of Biological Prosthetic Heart Valves With the "Easy Change" System
NCT044421001 location
EFS of the DUO System for Tricuspid Regurgitation
NCT0591390815 locations
Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease
NCT076178441 location